• News (226)
    Financial Times (07 Apr 2020)

    COVID-19: GSK buys $250m biotech stake in hunt for Covid-19 treatment

    GLAXOSMITHKLINE has acquired a six per cent stake in Vir Biotechnology as it looks to develop a treatment for coronavirus. The pharmaceutical giant invested £203m in the San  Francisco-based start-up.

    Read Full Article

    PR Newswire (10 Mar 2020)

    Angelini Pharma Acquires ThermaCare® From GSK

    GLAXOSMITHKLINE has sold its rights to the heat therapy ThermaCare business to Angelini Pharma. 

    Read Full Article